Formula 4 Injection recalled over sterility concerns
- Recall date
- March 14, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Meditech Laboratories, Inc recalls Formula 4 (Papaverine 18 mg, Phentolamine 2 mg, Atropine 0.2 mg/mL) Injection, 5 mL vials, Rx only, Meditech Laboratori…
- Recall number
- D-0803-2016
- FDA classification
- Class II
- Brand / firm
- Meditech Laboratories, Inc
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility: incomplete or missing data regarding production.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Formula 4 (Papaverine 18 mg, Phentolamine 2 mg, Atropine 0.2 mg/mL) Injection, 5 mL vials, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102. .
Get recall alerts
Free email alert whenever Meditech Laboratories, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Meditech Laboratories, Inc